---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-010049"
form_type: "8-K"
ticker: "ERNA"
cik: "0000748592"
company_name: "Ernexa Therapeutics Inc."
filed_at: "2025-03-12T23:59:59+00:00"
generated_at: "2026-05-24T22:52:34.435536+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Eterna Therapeutics issues $1.5M promissory note to Charles Cherington at 5%

## Summary
- Principal amount $1,500,000 at 5.0% annual interest, paid at maturity.
- Matures June 15, 2025, or earlier if Eterna raises >$5M in equity or convertible debt.
- Default rate set at 7.0% per annum on overdue amounts.
- Proceeds received on March 11, 2025; loan can be prepaid without penalty.
- Cross-default triggered if Eterna fails to pay >$50K in other debt after grace period.

## SEC filing metadata
- accession: 0001493152-25-010049
- form_type: 8-K
- ticker: ERNA
- cik: 0000748592
- company_name: Ernexa Therapeutics Inc.
- filed_at: 2025-03-12T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/748592/000149315225010049/0001493152-25-010049-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/748592/000149315225010049/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-010049
- JSON: https://secwatch.observer/filing/0001493152-25-010049.json
- Plain text: https://secwatch.observer/filing/0001493152-25-010049.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.